It was reported the patient had a loss of therapeutic effect.The patient went to their healthcare provider¿s office the day of report with a return of symptoms.The patient stated they were hospitalized for this before but no one checked out the settings.The patient¿s device was set at 5 volts at the time of report and the patient stated that at their last visit they had been programmed to 7.8 volts and had been therapeutic at that level.The patient noted their return of symptoms started two weeks prior to report.The impedances were greater than 800 ohms and therefore it would not autocalculate and the health care provider was trying to determine what to set the voltage at.The patient¿s battery was at greater than 120 months.A longevity calculation indicated 22.09 months at a 7.8 volt reading factoring in that voltage being used since implant, however it had not been at 7.8 volts since implant.The patient started out at 3.3 volts in (b)(6) and had increased to 3.9 volts by (b)(6).The device impedance measurements recorded the day of report, in (b)(6), were all within normal range.Though, it was noted that the impedances had risen 150 ohms over time.The patient was reprogrammed at 7.8 volts as that was the last therapeutic setting.It was stated that the manufacturer representative was suspicious of lead migration due to the 150 point shift in impedances and x-rays and further testing was suggested to verify lead migration issues.No interventions or outcome were reported regarding this event.Further follow-up is being conducted to obtain this information.If additional information is received, a follow-up report will be sent.
|
Concomitant medical products: product id 4351-35, serial# (b)(4), implanted: (b)(6) 2013, product type: lead; product id 4351-35, serial# (b)(4), implanted: (b)(6) 2013, product type: lead; product id 4351-35, serial# (b)(4), implanted: (b)(6) 2013, product type: lead; product id 4351-35, serial# (b)(4), implanted: (b)(6) 2013, product type: lead.(b)(4).
|